Source - RNS
RNS Number : 8937G
Keras Resources PLC
01 June 2017

Keras Resources plc / Index: AIM / Epic: KRS / Sector: Mining

1 June 2017

Keras Resources plc ('Keras' or 'the Company')

Conditional Approval for Listing of Calidus Resources Limited received from ASX


Keras Resources plc, the AIM listed mineral resource company is pleased to advise that the ASX has today given conditional approval for the shares of Pharmanet Group Limited ("Pharmanet"), to be reinstated to trading on the ASX.  As previously announced, upon restoration, Pharmanet will be renamed Calidus Resources Limited ("Calidus").


The approval is conditional on various statutory and mechanical events and includes the ASX receiving signed restriction agreements from various related parties. The conditional approval also included notification that the ASX has elected to assign a 24-month escrow period on the Company's shareholding in Calidus as opposed to the 12-month escrow period that was announced previously.


The Company and Pharmanet are now working to achieve the final allotment of shares relating to the ASX capital raising which will enable the final conditions to be satisfied and allow trading of Calidus to commence on the ASX soon thereafter.


This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.




For further information please visit, follow us on Twitter @kerasplc or contact the following:


Dave Reeves

Keras Resources plc

[email protected]


Nominated Adviser

Gerry Beaney/David Hignell

Northland Capital Partners Limited

+44 (0) 20 3861 6625



Elliot Hance/Jonathon Belliss

Damon Heath/Erik Woolgar

Beaufort Securities Limited

Shard Capital Partners LLP

+44 (0) 20 7382 8415

+44 (0) 20 7186 9952

Tom Curran/Ben Tadd

SVS Securities Plc

+44 (0) 203 700 0093


Financial PR

Susie Geliher/Charlotte Page

St Brides Partners Limited

+44 (0) 20 7236 1177



This information is provided by RNS
The company news service from the London Stock Exchange